- Study supports long-term cardiovascular safety of Tradjenta® (linagliptin) in adults with type 2 diabetes
PR Newswire
RIDGEFIELD, Conn. and INDIANAPOLIS, July 19, 2018
PR Newswire
RIDGEFIELD, Conn. and INDIANAPOLIS, July 19, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey